# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
-Reuters
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quar...
On Friday, 93 stocks made new 52-week lows.
During Tuesday, 95 stocks hit new 52-week lows.
On Thursday, 175 stocks hit new 52-week lows.
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly imp...